Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Pfizer goes from villain to hero

The company lands fourth on Fortune magazine’s list of most admired companies

Axios

Albanese demands Colbeck ‘resign today’ as nation records 82 Covid deaths – as it happened

This blog is now closed

The Guardian - AU

ATAGI approves Pfizer COVID-19 vaccine booster shots for 16 and 17-year-olds

Australia's vaccine advisory body approves a third dose of Pfizer's COVID-19 vaccine for 16 and 17-year-olds.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson recipients can get third COVID shot in San Francisco

SAN FRANCISCO — San Francisco health officials are allowing people who originally got the Johnson & Johnson COVID-19 vaccine to get a second booster shot — which would give them access to the same number of doses currently available to recipients of Pfizer-BioNTech or Moderna.

Los Angeles Times

EXPLAINER: COVID vaccines for kids under 5: What's next?

COVID-19 vaccines for kids under 5 may be available in the U.S. as early as March, but there are several hurdles still to clear

The Independent UK

Q&A: What to know about Pfizer’s COVID-19 vaccine for kids under age 5

The Food and Drug Administration said Tuesday it will consider authorizing Pfizer’s COVID-19 vaccine for kids as young as 6 months, opening the door to immunizing some 23 million American children for whom vaccines haven’t yet been available.

Tribune News Service

France to start using Pfizer's COVID-19 drug, first in EU

France says it will start administering Pfizer’s coronavirus antiviral drug this week, the first pill for treating COVID-19 approved in the 27-nation EU

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

FDA Asks Pfizer - BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have

Benzinga

Pfizer seeks US authorization of Covid vaccine for children under five

FDA decision could come within weeks but big obstacles remain to getting all children inoculated

The Guardian - US

Pfizer Seeks US Approval of Covid Vaccine for Children under 5

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to…

Asharq Al-Awsat

Study confirms effectiveness of COVID-19 booster vaccinations

A new study from the Center for Disease Control and Prevention confirms what Mayo Clinic and other experts have been saying: COVID-19 booster vaccinations improve protection against severe illness and hospitalization. The study examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether…

Tribune News Service

Covid news: Anger as Tory MP says lockdown breach ‘like parking fine’; Germany could relax restrictions in March – as it happened

Pfizer-BioNTech seeks US approval for under-5s Covid inoculation; Lithuania to scrap Covid pass on Saturday

The Guardian - AU

Pfizer seeks approval for giving Covid shots to children six months and up as US death toll nears a million

So far, Pfizer’s vaccine has only been available to people at least five years old

The Independent UK

Pfizer asks FDA to authorize COVID vaccine for kids under 5

Hospitalizations of children under 5 have reached their highest levels since the beginning of the pandemic.

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Pfizer seeking FDA clearance for COVID shot in children under 5

Pfizer Inc. and partner BioNTech SE have begun submitting data to U.S. regulators for authorization of their COVID-19 vaccine in children 6 months to 4 years old, according to people familiar with the matter, hastening an effort to get shots to younger kids after the omicron wave caused pediatric infections…

Benzinga

FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment

The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension

ABC News

COVID pills, a holy grail vaccine and 'immune fitness': Why there's a virus 'recalibration' coming

Experts predict 2022 will be the year COVID stops defining our lives. The virus isn't going away but new treatments and ways of thinking could mark the beginning of the end.

Bristol Post

Covid-19 vaccines: People with allergies urged to book booster jab

People with allergies are told it is safe to get the jab

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Under 5s may be weeks away from Covid shots – what you need to know

Vaccine may be available to youngsters below the age of five from February, if FDA approval is granted

Newsroom.co.nz

Government paid $36.50 per dose of Pfizer vaccine

Documents obtained by Newsroom under the Official Information Act reveal the numbers the Government has been trying to keep secret - how much New Zealand paid for its vaccines.

Daily Mirror

Covid booster crisis as people with allergies told they can have Pfizer jab

The message that Pfizer was not suitable for people with allergies, especially those with a history of anaphylaxis, spread far and wide - but it is simply not true

The Guardian - AU

Omicron sub-variant detected in 57 countries, says WHO – as it happened

This blog is now closed

Axios

COVID vaccines could be available for kids under 5 by end of February

Pfizer is expected to submit a request to the FDA as soon as tomorrow for emergency-use authorization.

The Independent UK

AP source: US urges Pfizer to apply for under-5 COVID shots

U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old

Benzinga

Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) are likely to submit a request for an emergency use authorization to the U.S.

1 … 67 68 69 70

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

2,555 stories

Pfizer

1,773 stories

World Health Organization

Bureau of Meteorology

524 stories

454 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.